Department of Physical Medicine & Rehabilitation, University of Missouri, Columbia, MO, USA.
NextGen Precision Health, University of Missouri, Columbia, MO, USA.
Ann Clin Transl Neurol. 2023 Dec;10(12):2208-2222. doi: 10.1002/acn3.51906. Epub 2023 Sep 21.
To test the hypotheses that decomposition electromyography (dEMG) motor unit action potential (MUAP) amplitude and firing rate are altered in SMA; dEMG parameters are associated with strength and function; dEMG parameters are correlated with traditional electrophysiological assessments.
Ambulatory and non-ambulatory adults with SMA on nusinersen and healthy controls were enrolled. MUAPs were decomposed from multielectrode surface recordings during 30-s maximum contraction of the abductor digiti minimi (ADM). Isometric strength, upper limb function, patient-reported function, and standard electrophysiologic measures of the ADM (compound muscle action potential [CMAP], single motor unit potential [SMUP], motor unit number estimation [MUNE]) were collected.
dEMG MUAP amplitudes were higher in ambulatory versus control and non-ambulatory groups and were higher in controls versus non-ambulatory SMA. In contrast, dEMG firing rates were higher in ambulatory versus non-ambulatory and control groups but similar between non-ambulatory and control. dEMG parameters showed moderate to strong positive correlation with strength and function whereas CMAP and MUNE better correlated with function than strength. SMUP did not correlate with strength, function, or dEMG MUAP amplitude. dEMG parameters show overall good test-retest reliability.
dEMG provided reliable, noninvasive measure of MUAP amplitude size and firing rate and revealed divergent patterns across disease severity in adults with SMA. Firing rate enhancement, as seen in milder SMA, may provide a therapeutic avenue for improving function in more severe SMA, where firing rates appear preserved. MUAP amplitude size and firing rate, quantified with dEMG, may be promising monitoring biomarker candidates for noninvasive assessment of SMA.
验证以下假设,即 SMA 中分解肌电图(dEMG)运动单位动作电位(MUAP)幅度和放电率发生改变;dEMG 参数与强度和功能相关;dEMG 参数与传统电生理评估相关。
纳入正在接受 nusinersen 治疗的 SMA 门诊和非门诊成人患者及健康对照者。在 30 秒最大趾展肌收缩期间,从多电极表面记录中分解 MUAP。采集等长强度、上肢功能、患者报告的功能以及趾展肌的标准电生理测量(复合肌肉动作电位[CMAP]、单个运动单位电位[SMUP]、运动单位数量估计[MUNE])。
与对照组和非门诊 SMA 组相比,门诊组的 dEMG MUAP 幅度更高,而对照组的 dEMG MUAP 幅度高于非门诊 SMA 组。相反,与非门诊和对照组相比,门诊组的 dEMG 放电率更高。dEMG 参数与强度和功能呈中等到高度正相关,而 CMAP 和 MUNE 与功能的相关性优于与强度的相关性。SMUP 与强度、功能或 dEMG MUAP 幅度均无相关性。dEMG 参数的整体测试-重测可靠性良好。
dEMG 提供了 MUAP 幅度大小和放电率的可靠、非侵入性测量方法,揭示了不同严重程度的 SMA 成人的不同模式。在轻度 SMA 中观察到的放电率增强可能为改善更严重 SMA 中的功能提供了一种治疗途径,在更严重的 SMA 中,放电率似乎得到了保留。用 dEMG 量化的 MUAP 幅度大小和放电率可能是 SMA 无创评估有前途的监测生物标志物候选者。